Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows

v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Aug. 31, 2025
Aug. 31, 2024
Cash flows from operating activities:    
Net (loss) income $ (5,540) $ 19,227
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Amortization and depreciation 4 5
Amortization of discount on convertible notes   125
Loss on derivatives   852
Loss on induced conversion   1,180
Stock-based compensation 179 136
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 1,989 (1,783)
Accounts payable, accrued expenses, and other liabilities 918 (14,302)
Net cash (used in) provided by operating activities (2,450) 5,440
Cash flows from investing activities:    
Net cash provided by/used in investing activities
Cash flows from financing activities:    
Proceeds from warrant transactions, net of offering costs   10,377
Proceeds from exercise of stock options 21  
Cash paid for note payable (142) (710)
Net cash (used in) provided by financing activities (121) 9,667
Net change in cash and cash equivalents (2,571) 15,107
Cash and cash equivalents at beginning of period 11,903 9,814
Cash and cash equivalents at end of period 9,332 24,921
Supplemental disclosure:    
Cash paid for interest 13 45
Non-cash investing and financing transactions:    
Issuance of common stock for interest of convertible notes 2,250 1,000
Accrued dividends on Series C and D convertible preferred stock $ 373 $ 372